If they succeed, it could affect about 7,000 international scholars and potentially deliver a disabling blow to the campus’s finances, curriculum and identity.

A private equity firm has stepped in to finance a biological research lab at Harvard University, administrators said Monday, while also launching a biotech alongside it that will develop new therapie...